Quest Pharmatech Inc banner
Q

Quest Pharmatech Inc
XTSX:QPT

Watchlist Manager
Quest Pharmatech Inc
XTSX:QPT
Watchlist
Price: 0.03 CAD Market Closed
Market Cap: CA$5.1m

Quest Pharmatech Inc
Investor Relations

Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. The company is headquartered in Edmonton, Alberta. The firm is focused on development and commercialization of immunotherapies for cancer. Its technology platform includes a portfolio of tumor antigen specific monoclonal immunoglobulins targeting CA-125, MUC1, PSA and Her2/neu. The firm is also developing products utilizing transdermal delivery technologies with a focus on dermatology and wound healing applications. The firm is exploring the therapeutic potential of these antibodies as indirect immunizers in combination with other immune modulating drugs or drug combinations to address unmet medical needs in oncology.

Show more
Loading
QPT
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Ragupathy Madiyalakan Ph.D.
CEO & Director
No Bio Available
Mr. Pierre Vermette C.A., CPA
Chief Financial Officer
No Bio Available
Mr. Roger Andrews
Head of Investor Relations & Corporate Communications
No Bio Available
Mr. Douglas C. Bachman
Vice President of Corporate Development
No Bio Available
Mr. Thomas Woo
Vice President of Product Development
No Bio Available

Contacts

Address
ALBERTA
Edmonton
8123 Roper Rd NW
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett